Atai Life Sciences Free Cash Flow 2020-2024 | ATAI
Atai Life Sciences free cash flow from 2020 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Atai Life Sciences Annual Free Cash Flow |
| 2024 |
-82.44 |
| 2023 |
-84.38 |
| 2022 |
-105.24 |
| 2021 |
-63.42 |
| 2020 |
-20.83 |
| 2019 |
-7.87 |
| Atai Life Sciences Quarterly Free Cash Flow |
| 2024-12-31 |
-82.44 |
| 2024-09-30 |
-58.14 |
| 2024-06-30 |
-38.80 |
| 2024-03-31 |
-22.57 |
| 2023-12-31 |
-84.38 |
| 2023-09-30 |
-62.41 |
| 2023-06-30 |
-43.98 |
| 2023-03-31 |
-21.39 |
| 2022-12-31 |
-105.24 |
| 2022-09-30 |
-74.59 |
| 2022-06-30 |
-46.09 |
| 2022-03-31 |
-24.04 |
| 2021-12-31 |
-63.42 |
| 2021-09-30 |
-42.86 |
| 2021-06-30 |
-14.93 |
| 2021-03-31 |
-16.70 |
| 2020-12-31 |
-20.83 |
| 2020-09-30 |
-14.56 |
| 2020-06-30 |
-9.12 |
| 2020-03-31 |
-3.89 |
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-OUTP/HM CRE |
$0.294B |
$0.000B |
|
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|
